ArticleJournal of translational medicine2025

SH3BP5-driven metabolic-immune crosstalk in DLBCL: a prognostic biomarker and therapeutic target for reshaping immunosuppressive microenvironment.

Tong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.